Deakin University
Browse

P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In

Version 2 2024-06-06, 05:21
Version 1 2023-03-17, 05:06
conference contribution
posted on 2024-06-06, 05:21 authored by Anna Nowak, Peey-Sei Kok, Ann LivingstoneAnn Livingstone, Willem Joost Lesterhuis, Sonia Yip, Mark Donoghoe, Wei-Sen Lam, Martin Stockler
P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In

History

Journal

Journal of Thoracic Oncology

Volume

12

Pagination

S1086-S1087

Publisher DOI

ISSN

1556-0864

Language

en

Publication classification

C2 Other contribution to refereed journal

Title of proceedings

Journal of Thoracic Oncology

Issue

1

Publisher

Elsevier BV

Publication URL

Usage metrics

    Research Publications

    Categories

    Keywords

    Uncategorised value

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC